The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

Elevaris Medical Devices, a Contract Development and Manufacturing Organization (CDMO) for industry-leading, multi-national healthcare companies, global medical device manufacturers, and emerging ...